(NN) NN - Overview
Stock: Insurance, Banking, Pensions, Investments, Reinsurance
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 6.28% |
| Yield on Cost 5y | 14.02% |
| Yield CAGR 5y | 10.20% |
| Payout Consistency | 99.2% |
| Payout Ratio | 2.7% |
| Risk 5d forecast | |
|---|---|
| Volatility | 20.0% |
| Relative Tail Risk | -12.1% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.48 |
| Alpha | 58.97 |
| Character TTM | |
|---|---|
| Beta | 0.033 |
| Beta Downside | 0.154 |
| Drawdowns 3y | |
|---|---|
| Max DD | 21.11% |
| CAGR/Max DD | 1.48 |
Description: NN NN January 02, 2026
NN Group N.V. (ticker NN) is a Dutch-based financial services group that offers a full suite of life and non-life insurance, banking, and pension products to individuals, SMEs, and corporate clients across the Netherlands and select international markets.
The firm operates through six segments: Netherlands Life, Netherlands Non-Life, Insurance Europe, Japan Life, Banking, and “Other” (including reinsurance and retirement services). Distribution channels comprise tied agents, bancassurance partners, brokers, and direct digital sales.
In 2023 the company reported net written premiums of roughly €16.5 bn, a combined ratio of 95 % in its core insurance business, and a return on equity of about 12 %, supporting a dividend yield near 5 %.
Key drivers of NN’s outlook include persistently low interest-rate environments that pressure investment income, rising inflation that can lift premium volumes, and demographic aging in Europe that fuels demand for pension and longevity products. Regulatory capital constraints under Solvency II also shape capital allocation decisions.
If you want a data-rich, quantitative deep-dive, consider checking the ValueRay platform’s analyst dashboards for additional metrics and scenario analyses.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 1.33b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA 0.30 > 1.0 |
| NWC/Revenue: 698.8% < 20% (prev 45.23%; Δ 653.6% < -1%) |
| CFO/TA 0.00 > 3% & CFO 249.0m > Net Income 1.33b |
| Net Debt (5.32b) to EBITDA (9.42b): 0.56 < 3 |
| Current Ratio: 7.27 > 1.5 & < 3 |
| Outstanding Shares: last quarter (266.7m) vs 12m ago -2.56% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 6.78% > 50% (prev 6.30%; Δ 0.48% > 0%) |
| Interest Coverage Ratio: 3.35 > 6 (EBITDA TTM 9.42b / Interest Expense TTM 1.31b) |
Altman Z'' 3.25
| A: 0.47 (Total Current Assets 112.98b - Total Current Liabilities 15.55b) / Total Assets 206.11b |
| B: -0.01 (Retained Earnings -2.94b / Total Assets 206.11b) |
| C: 0.02 (EBIT TTM 4.39b / Avg Total Assets 205.66b) |
| D: 0.05 (Book Value of Equity 9.06b / Total Liabilities 184.38b) |
| Altman-Z'' Score: 3.25 = A |
What is the price of NN shares?
Over the past week, the price has changed by +1.03%, over one month by +3.66%, over three months by +12.66% and over the past year by +63.52%.
Is NN a buy, sell or hold?
What are the forecasts/targets for the NN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 67.7 | -1.1% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 92.9 | 35.6% |
NN Fundamental Data Overview February 09, 2026
P/E Trailing = 14.641
P/E Forward = 8.5985
P/S = 1.2453
P/B = 0.8316
P/EG = 0.7164
Revenue TTM = 13.94b EUR
EBIT TTM = 4.39b EUR
EBITDA TTM = 9.42b EUR
Long Term Debt = 13.08b EUR (from longTermDebt, last quarter)
Short Term Debt = 2.80b EUR (from shortTermDebt, last fiscal year)
Debt = 13.08b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.32b EUR (from netDebt column, last quarter)
Enterprise Value = 23.32b EUR (18.00b + Debt 13.08b - CCE 7.76b)
Interest Coverage Ratio = 3.35 (Ebit TTM 4.39b / Interest Expense TTM 1.31b)
EV/FCF = 93.65x (Enterprise Value 23.32b / FCF TTM 249.0m)
FCF Yield = 1.07% (FCF TTM 249.0m / Enterprise Value 23.32b)
FCF Margin = 1.79% (FCF TTM 249.0m / Revenue TTM 13.94b)
Net Margin = 9.51% (Net Income TTM 1.33b / Revenue TTM 13.94b)
Gross Margin = unknown ((Revenue TTM 13.94b - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = 0.11 (Enterprise Value 23.32b / Total Assets 206.11b)
Interest Expense / Debt = 10.01% (Interest Expense 1.31b / Debt 13.08b)
Taxrate = 25.0% (66.0m / 264.0m)
NOPAT = 3.29b (EBIT 4.39b * (1 - 25.00%))
Current Ratio = 7.27 (Total Current Assets 112.98b / Total Current Liabilities 15.55b)
Debt / Equity = 0.60 (Debt 13.08b / totalStockholderEquity, last quarter 21.64b)
Debt / EBITDA = 0.56 (Net Debt 5.32b / EBITDA 9.42b)
Debt / FCF = 21.36 (Net Debt 5.32b / FCF TTM 249.0m)
Total Stockholder Equity = 21.61b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.64% (Net Income 1.33b / Total Assets 206.11b)
RoE = 6.14% (Net Income TTM 1.33b / Total Stockholder Equity 21.61b)
RoCE = 12.66% (EBIT 4.39b / Capital Employed (Equity 21.61b + L.T.Debt 13.08b))
RoIC = 9.71% (NOPAT 3.29b / Invested Capital 33.91b)
WACC = 6.65% (E(18.00b)/V(31.08b) * Re(6.03%) + D(13.08b)/V(31.08b) * Rd(10.01%) * (1-Tc(0.25)))
Discount Rate = 6.03% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -1.72%
[DCF Debug] Terminal Value 76.80% ; FCFF base≈249.0m ; Y1≈163.5m ; Y5≈74.6m
Fair Price DCF = N/A (negative equity: EV 1.93b - Net Debt 5.32b = -3.39b; debt exceeds intrinsic value)
EPS Correlation: -45.49 | EPS CAGR: -49.89% | SUE: 0.0 | # QB: 0
Revenue Correlation: 10.98 | Revenue CAGR: -7.83% | SUE: 1.65 | # QB: 1
EPS next Year (2026-12-31): EPS=8.03 | Chg30d=+0.031 | Revisions Net=+1 | Growth EPS=+9.4% | Growth Revenue=+3.6%